Aarti Drugs Ltd

Aarti Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aarti Drugs Ltd

₹ 368 1.49%
15 May - close price
aartidrugs.com BSE: 524348 NSE: AARTIDRUGS
About

Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. [1]

It is exporting its API's and Speciality chemicals to over 100 countries across the globe. [2]

Key Points

Market Leadership
The company is a leading global producer of 50+ API molecules across categories like antibiotics, antiprotozoal, anti-inflammatory, anti-diabetic, and anti-fungal. It is the largest manufacturer of Fluoroquinolones, Tinidazole, Metronidazole Benzoate, Celecoxib, Nimesulide, and Ketoconazole worldwide, and among the top producers of Metformin globally. [1] [2]

Website BSE NSE
  • Market Cap ₹ 3,356 Cr.
  • Current Price ₹ 368
  • High / Low ₹ 575 / 319
  • Stock P/E 19.8
  • Book Value ₹ 154
  • Dividend Yield 0.54 %
  • ROCE 11.6 %
  • ROE 12.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 3.37% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 12.7% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 4.09% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -4.55%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare Nifty500 Shariah Nifty Microcap 250 Nifty Total Market BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
696 592 578 538 560 493 543 515 623 521 579 529 632
608 520 512 478 490 439 484 454 534 457 504 486 552
Operating Profit 89 72 65 60 69 54 60 60 89 64 75 42 79
OPM % 13% 12% 11% 11% 12% 11% 11% 12% 14% 12% 13% 8% 13%
1 1 1 2 1 0 0 11 2 0 0 1 1
Interest 8 8 8 7 8 7 7 8 7 7 6 7 7
Depreciation 12 12 12 12 12 12 12 12 12 12 14 15 15
Profit before tax 69 53 47 43 50 35 41 52 71 45 56 22 59
Tax % 23% 25% 26% 26% 27% 23% 26% 26% 13% -7% 25% -56% 23%
53 40 35 32 36 27 30 39 61 49 42 34 45
EPS in Rs 5.74 4.27 3.76 3.44 3.93 2.93 3.33 4.22 6.74 5.33 4.58 3.71 4.93
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1,087 1,076 1,089 1,140 1,454 1,635 1,915 2,251 2,498 2,267 2,174 2,260
915 900 910 955 1,252 1,387 1,511 1,930 2,212 1,998 1,908 2,000
Operating Profit 172 176 179 185 203 248 404 321 286 269 265 261
OPM % 16% 16% 16% 16% 14% 15% 21% 14% 11% 12% 12% 12%
1 0 4 1 6 9 7 5 2 4 14 3
Interest 42 47 38 36 41 36 26 23 36 33 32 26
Depreciation 31 36 37 38 40 47 48 47 47 48 48 56
Profit before tax 100 93 108 112 128 175 338 256 205 192 199 181
Tax % 22% 29% 30% 35% 32% 22% 24% 24% 25% 26% 21% 7%
78 66 75 73 87 136 258 195 153 142 157 169
EPS in Rs 8.01 6.84 7.91 7.78 9.25 14.56 27.65 21.06 16.50 15.43 17.24 18.54
Dividend Payout % 41% 25% 3% 3% 3% 3% 9% 5% 6% 6% 6% 0%
Compounded Sales Growth
10 Years: 8%
5 Years: 3%
3 Years: -3%
TTM: 4%
Compounded Profit Growth
10 Years: 10%
5 Years: -8%
3 Years: 3%
TTM: 8%
Stock Price CAGR
10 Years: 12%
5 Years: -13%
3 Years: -8%
1 Year: -19%
Return on Equity
10 Years: 17%
5 Years: 14%
3 Years: 13%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 24 24 24 24 24 23 93 93 93 92 91 91
Reserves 279 326 363 410 495 598 766 880 1,022 1,083 1,160 1,314
435 465 448 517 471 378 336 519 535 475 516 421
228 240 281 366 384 471 442 543 546 522 506 556
Total Liabilities 967 1,055 1,116 1,316 1,373 1,471 1,637 2,035 2,196 2,172 2,273 2,382
431 463 542 564 586 612 631 649 634 722 761 971
CWIP 13 34 14 28 32 11 16 60 161 222 273 106
Investments 11 11 18 17 19 20 24 28 29 30 42 72
511 547 541 707 736 828 966 1,297 1,372 1,198 1,196 1,232
Total Assets 967 1,055 1,116 1,316 1,373 1,471 1,637 2,035 2,196 2,172 2,273 2,382

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
107 125 174 62 147 196 154 40 162 337 220 254
-102 -87 -96 -71 -59 -29 -69 -125 -131 -187 -135 -128
-5 -37 -78 9 -87 -168 -85 84 -31 -149 -85 -126
Net Cash Flow -1 1 -0 -0 1 -1 -0 -1 0 1 1 0
Free Cash Flow 10 37 78 -10 87 164 80 -87 31 148 83 152
CFO/OP 71% 83% 108% 45% 87% 94% 60% 37% 76% 144% 103% 94%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 103 109 93 117 110 104 96 115 117 104 118 118
Inventory Days 77 87 101 132 86 107 125 120 102 107 106 102
Days Payable 75 85 91 125 86 110 94 103 89 96 97 104
Cash Conversion Cycle 105 110 103 124 109 101 127 133 130 115 127 116
Working Capital Days 13 21 26 33 46 60 83 68 73 79 79 80
ROCE % 21% 18% 17% 17% 17% 20% 33% 21% 15% 14% 14% 12%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Captive Production Consumption
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Net Production Volume
MTPA
Total Installed Capacity
MTPA
Total Production Volume
MTPA
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
58.70% 58.57% 57.47% 57.13% 55.67% 55.64% 55.38% 55.48% 55.23% 54.72% 55.03% 55.03%
1.97% 2.33% 2.10% 2.56% 2.95% 2.50% 2.28% 2.25% 2.26% 2.68% 2.15% 1.57%
4.72% 5.32% 5.26% 5.99% 7.35% 7.83% 8.77% 9.70% 9.94% 9.90% 10.12% 10.22%
34.63% 33.78% 35.16% 34.30% 34.01% 34.01% 33.58% 32.57% 32.58% 32.70% 32.71% 33.19%
No. of Shareholders 1,62,4091,67,4461,70,4141,57,5471,50,2181,90,2811,76,0061,69,7611,60,2601,52,2521,48,3631,44,946

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls